| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥1.42B | ¥1.39B | +1.7% |
| Cost of Sales | ¥763M | ¥724M | +5.3% |
| Gross Profit | ¥652M | ¥669M | -2.4% |
| SG&A Expenses | ¥525M | ¥939M | -44.1% |
| Operating Income | ¥127M | ¥-270M | +147.0% |
| Non-operating Income | ¥6M | ¥2M | +228.3% |
| Non-operating Expenses | ¥22,000 | ¥0 | - |
| Ordinary Income | ¥133M | ¥-268M | +149.6% |
| Profit Before Tax | ¥96M | ¥-282M | +134.1% |
| Income Tax Expense | ¥12M | ¥8M | +47.0% |
| Net Income | ¥84M | ¥-290M | +129.0% |
| Net Income Attributable to Owners | ¥83M | ¥-290M | +128.6% |
| Total Comprehensive Income | ¥84M | ¥-290M | +129.0% |
| Basic EPS | ¥3.21 | ¥-11.09 | +128.9% |
| Dividend Per Share | ¥0.00 | ¥0.00 | - |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥6.54B | ¥6.60B | ¥-56M |
| Cash and Deposits | ¥4.81B | ¥4.96B | ¥-145M |
| Accounts Receivable | ¥441M | ¥224M | +¥217M |
| Inventories | ¥320M | ¥370M | ¥-50M |
| Non-current Assets | ¥253M | ¥216M | +¥37M |
| Item | Value |
|---|---|
| Net Profit Margin | 5.9% |
| Gross Profit Margin | 46.1% |
| Current Ratio | 828.8% |
| Quick Ratio | 788.3% |
| Debt-to-Equity Ratio | 0.14x |
| Effective Tax Rate | 12.6% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +1.6% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 26.16M shares |
| Treasury Stock | 2 shares |
| Average Shares Outstanding | 26.16M shares |
| Book Value Per Share | ¥228.76 |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥0.00 |
| Year-End Dividend | ¥5.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| ClinicalEvidenceService | ¥101M | ¥13M |
| FunctionalCosmeticRetailing | ¥522M | ¥76M |
| FunctionalFoodRetailing | ¥485M | ¥78M |
| FunctionalMaterialDevelopment | ¥85M | ¥7M |
| HealthCareSupportService | ¥230M | ¥38M |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥4.00B |
| Operating Income Forecast | ¥50M |
| Ordinary Income Forecast | ¥55M |
| Net Income Attributable to Owners Forecast | ¥30M |
| Basic EPS Forecast | ¥1.15 |
| Dividend Per Share Forecast | ¥0.00 |
| Property, Plant & Equipment | ¥43M | ¥10M | +¥33M |
| Intangible Assets | ¥17M | ¥19M | ¥-2M |
| Investment Securities | ¥26M | ¥26M | ¥0 |
| Total Assets | ¥6.79B | ¥6.81B | ¥-18M |
| Current Liabilities | ¥789M | ¥756M | +¥33M |
| Accounts Payable | ¥161M | ¥191M | ¥-30M |
| Non-current Liabilities | ¥20M | ¥19M | +¥958,000 |
| Total Liabilities | ¥809M | ¥775M | +¥34M |
| Total Equity | ¥5.98B | ¥6.04B | ¥-53M |
| Capital Stock | ¥1.84B | ¥1.84B | ¥0 |
| Capital Surplus | ¥1.96B | ¥1.96B | +¥5M |
| Retained Earnings | ¥2.18B | ¥2.23B | ¥-47M |
| Treasury Stock | ¥-0 | ¥-0 | ¥0 |
| Owners' Equity | ¥5.98B | ¥6.02B | ¥-42M |
| Working Capital | ¥5.75B | - | - |